PubMed Health⌕ Search

PubMed · 16247292

Developing a sustainable process to provide quality control materials for genetic testing.

Abstract

PURPOSE: To provide a summary of the outcomes of two working conferences organized by the Centers for Disease Control and Prevention (CDC), to develop recommendations for practical, sustainable mechanisms to make quality control (QC) materials available to the genetic testing community. METHODS: Participants were selected to include experts in genetic testing and molecular diagnostics from professional organizations, government agencies, industry, laboratories, academic institutions, cell repositories, and proficiency testing (PT)/external Quality Assessment (EQA) programs. Current efforts to develop QC materials for genetic tests were reviewed; key issues and areas of need were identified; and workgroups were formed to address each area of need and to formulate recommendations and next steps. RESULTS: Recommendations were developed toward establishing a sustainable process to improve the availability of appropriate QC materials for genetic testing, with an emphasis on molecular genetic testing as an initial step. CONCLUSIONS: Improving the availability of appropriate QC materials is of critical importance for assuring the quality of genetic testing, enhancing performance evaluation and PT/EQA programs, and facilitating new test development. To meet the needs of the rapidly expanding capacity of genetic testing in clinical and public health settings, a comprehensive, coordinated program should be developed. A Genetic Testing Quality Control Materials Program has therefore been established by CDC in March 2005 to serve these needs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bin Chen, Catherine D O' Connell, D Joe Boone, Jean A Amos, Jeanne C Beck, Maria M Chan, Daniel H Farkas, Roger V Lebo, Carolyn Sue Richards, Benjamin B Roa, Lawrence M Silverman, David E Barton, Bassem A Bejjani, Dorothy R Belloni, Susan H Bernacki, Michele Caggana, Patricia Charache, Elisabeth Dequeker, Andrea Ferreira-Gonzalez, Kenneth J Friedman, Carol L Greene, Wayne W Grody, William Edward Highsmith, Cecelia S Hinkel, Lisa V Kalman, Ira M Lubin, Elaine Lyon, Deborah A Payne, Victoria M Pratt, Elizabeth Rohlfs, Clark A Rundell, Erasmus Schneider, Ann M Willey, Laurina O Williams, James C Willey, Emily S Winn-Deen, Daynna J Wolff. 2005. Developing a sustainable process to provide quality control materials for genetic testing.. https://doi.org/10.1097/01.gim.0000183043.94406.81

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The evolution of the CDC HIV prevention capacity-building assistance initiative.

As the HIV/AIDS epidemic neared the end of its first decade in the late 1980s, the US Centers for Disease Control and Prevention (CDC) recognized the disparate impact on racial and ethnic minority communities. In response, a program was initiated to build capacity to prevent the further spread of HIV and other STDs in these communities. Since that time, the program has expanded in scope, intensity of efforts, and funding. Today, the CDC's Capacity Building Assistance (CBA) Initiative serves communities across the nation by building community, organizational, and HIV prevention program/intervention capacity designed to reduce the number of new HIV infections among at-risk populations. This article focuses on the history and evolution of these efforts, lessons learned, and how these were used to develop the current, more responsive system. A conceptual framework is presented that describes the taxonomy of CBA services designed to (1) enhance organizational infrastructure; (2) enhance HIV prevention interventions; (3) strengthen community capacity; and (4) strengthen community planning. It includes language and definitions, approaches and mechanisms for delivering capacity-building services, and a Web-based request-and-referral system that serves as the foundation for tracking, monitoring, and ensuring the delivery of appropriate, efficient, and culturally competent CBA.

Centers for Disease Control and Prevention, U.S.↗